Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cobanerve-LC is an oral combination supplement developed and marketed by Invision Medi Sciences for the management of neuropathic conditions, including peripheral and diabetic neuropathy. The formulation contains three primary active ingredients: methylcobalamin (a bioactive form of Vitamin B12), l-carnitine l-tartrate, and folic acid (Vitamin B9). Methylcobalamin is essential for nerve regeneration and the synthesis of the myelin sheath, which protects nerve fibers. L-carnitine l-tartrate supports mitochondrial function and energy production, which is critical for maintaining nerve cell health and metabolic activity. Folic acid contributes to DNA synthesis and methylation processes necessary for nerve repair and maintenance. Together, these components work synergistically to support nerve function and alleviate symptoms associated with nerve damage and metabolic disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cobanerve-LC.